Glass House Brands (GLAS) Deferred Taxes (2020 - 2024)
Glass House Brands (GLAS) posted quarterly Deferred Taxes of $834000.0 for Q1 2024, up 990.35% year-over-year from $76489.0 in Q2 2023, and down 58.65% quarter-over-quarter from $2.0 million in Q4 2023.
Glass House Brands (GLAS) Deferred Taxes (2020 - 2024) Analysis & Trends
Glass House Brands (GLAS) has reported Deferred Taxes for 5 consecutive years, with $834000.0 the latest figure, recorded in Q1 2024.
- In Q1 2024, Deferred Taxes rose 990.35% year-over-year to $834000.0; the TTM figure through Mar 2024 stood at $2.3 million (up 124.08% YoY), while the FY2023 annual figure was $1.5 million, up 113.1% from the prior year.
- Deferred Taxes declined to $834000.0 in Q1 2024 per GLAS's latest filing, from $2.0 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $2.0 million in Q4 2023 and bottomed at -$9.5 million in Q4 2022.
- Historically, Deferred Taxes has averaged -$483739.2 across 5 years, with a median of -$34888.0 in 2021.
- Annual changes were most pronounced in 2022 — Deferred Taxes plunged 27046.6% — and 2024, when it soared 990.35%.
- Glass House Brands' Deferred Taxes stood at $1.1 million in 2020, then plunged by 103.09% to -$34888.0 in 2021, then slumped by 27046.6% to -$9.5 million in 2022, then jumped by 121.3% to $2.0 million in 2023, then slumped by 58.65% to $834000.0 in 2024.
- Business Quant data shows GLAS's Deferred Taxes at $834000.0 in Q1 2024, $2.0 million in Q4 2023, and -$226352.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Glass House Brands | 837.25 Mn | 818.69 Mn | 15.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 834,000.00 |
| Dec 31, 2023 | 2.02 Mn |
| Sep 30, 2023 | -226,352.00 |
| Jun 30, 2023 | -355,124.00 |
| Mar 31, 2023 | 76,489.00 |
| Dec 31, 2022 | -9.47 Mn |
| Sep 30, 2022 | 36,300.00 |
| Jun 30, 2022 | -67,132.00 |
| Mar 31, 2022 | -2.04 Mn |
| Dec 31, 2021 | -34,888.00 |
| Sep 30, 2021 | -49,920.00 |
| Jun 30, 2021 | -219,450.00 |
| Mar 31, 2021 | -57,797.00 |
| Dec 31, 2020 | 1.13 Mn |
| Sep 30, 2020 | 2,397.00 |
| Jun 30, 2020 | -18,127.00 |
| Mar 31, 2020 | 218,770.00 |